, Volume 59, Issue 1, pp 228–229 | Cite as

Effect of thyroid hormone suppression on control of advanced well-differentiated thyroid cancer

  • Nicole M. Iñiguez-Ariza
  • Marius N. Stan
  • Keith C. Bible
Endocrine Imaging


  1. 1.
    B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016).  https://doi.org/10.1089/thy.2015.0020 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    P. Pujol, J.P. Daures, N. Nsakala, L. Baldet, J. Bringer, C. Jaffiol, Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 81(12), 4318–4323 (1996).  https://doi.org/10.1210/jcem.81.12.8954034 PubMedGoogle Scholar
  3. 3.
    D.S. Cooper, B. Specker, M. Ho, M. Sperling, P.W. Ladenson, D.S. Ross, K.B. Ain, S.T. Bigos, J.D. Brierley, B.R. Haugen, I. Klein, J. Robbins, S.I. Sherman, T. Taylor, H.R. Maxon 3rd, Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid 8(9), 737–744 (1998)  https://doi.org/10.1089/thy.1998.8.737 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Mayo Clinic Division of Endocrinology, Diabetes, Metabolism, and NutritionRochesterUSA
  2. 2.Mayo Clinic Division of Medical OncologyRochesterUSA

Personalised recommendations